Accelerating drug discovery
PUBLIC CALL
March 30, 2020
March 30, 2020
Let’s fight COVID-19 together
Help us fight coronavirus by joining the COVID Moonshot (https://covid.postera.ai/covid), an initiative that aims to rapidly develop antiviral therapeutics via crowdsourcing. COVID Moonshot has experimentally obtained over 60 high quality structures of fragments bound to the main protease and is now asking for your ideas on which molecules we should make and test.
The second round of submission will close on Thursday, April 2nd midnight Pacific Time, but there will be more. Read more >>
172 723 Fragment compounds
including 27 000 Covalent fragments available from stock
Fragments
PRESS RELEASE
Mar 11, 2020
March 11, 2020
Enamine to be the exclusive supplier of Astex’ MiniFrag Library
Enamine Ltd. and Astex Pharmaceuticals (UK) have cooperated to provide wide access to Astex’ MiniFrag library, an efficient Fragment-based Drug Discovery tool for identification of hot and warm spots of protein targets. The Library is readily available from Enamine in any suitable format, including dry samples or assay-ready high concentration (1M, 100mM) aqueous soaks in containers of preferred type. The detected MiniFrag hits can be followed-up with a wide range of stock available and synthetically feasible derivatives as well as with building blocks for introduction of the relevant structural features for lead optimization. Read more >>
Reach out to new chemical space breaking the availability bias:
14 000 000 000 molecules and beyond
REAL compounds
NEWS
Mar 10, 2020
March 10, 2020
An open-source drug discovery platform enables ultra-large virtual screens
We are delighted to announce another application of Enamine REAL database recently published in Nature. This paper is a result of the collaborative effort of scientists from Enamine and the leading academic institutions from the USA and Germany. Read More >>
Ref.: Nature 2020, in press
Run HTS directly at Enamine or have your copy from
Ever-expanding collection of 3 million compounds
Screening Libraries & HTS
NEWS
Dec 12, 2019
December 12, 2019
New RNA targeted library has been created!
The number of targets, the number of diseases that one could go after by targeting RNA, is almost unimaginable, says Matt Disney, a chemist at the Scripps Research Institute.
In response to growing interest and recent advancements in targeting RNA our experts designed dedicated library of small molecules predicted to bind to RNA targets.
In contrast to the classical protein targets and disease treatment, drugging RNA reveals absolutely new way to treat and prevent different disorders.
Our freshly-made library is ready for fast shipment within a week in various custom formats.
RNA Library contains 8 960 compounds. Read more >>
The world's largest collection of building blocks in stock:
186 910 and counting
New Building Blocks
Scientific research and development of techniques for the synthesis of organic compounds
